Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michelle A Rudek (Michael A Carducci)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

Biomedical chromatography : BMC

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M R, Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A Rudek, Woon Nam Chow, Walter Stark, Laura M Ensign, Justin Hanes, Qingguo Xu
Six-month effective treatment of corneal graft rejection. Science advances 9 (12) (2023)
Missak Haigentz, Jeannette Y Lee, Elizabeth Yu Chiao, David M Aboulafia, Lee Ratner, Richard F Ambinder, Robert A Baiocchi, Ronald T Mitsuyasu, William Wachsman, Joseph A Sparano, Michelle A Rudek
Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4 interacting antiretroviral therapy in people living HIV and cancer (AMC087). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M R, Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A Rudek, Woon Nam Chow, Walter Stark, Laura M Ensign, Justin Hanes, Qingguo Xu
Six-month effective treatment of corneal graft rejection. Science advances 9 (12) (2023)
Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Jablonski Horton, Joseph Mock, Michael Hanley, Kyeongmin Kim, Michelle A Rudek, Mitch A Phelps, Michael A Carducci, Richard L Piekarz, Kwon-Sik Park, Timothy N J Bullock, Charles M Rudin
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399. The oncologist (2023)
Amanda B Kagan, Dominique A Garrison, Nicole M Anders, Jonathan A Webster, Sharyn D Baker, Srinivasan Yegnasubramanian, Michelle A Rudek
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities. Clinical and translational science (2023)
Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M R, Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A Rudek, Woon Nam Chow, Walter Stark, Laura M Ensign, Justin Hanes, Qingguo Xu
Six-month effective treatment of corneal graft rejection. Science advances 9 (12) (2023)
Amanda B Kagan, Blake S Moses, Rena Lapidus, Bryan T Mott, Ganesha Rai, Nicole M Anders, Stephen W Hoag, Michelle A Rudek, Curt I Civin
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative. Cancer chemotherapy and pharmacology (2023)
Michael T Davis, Nicole M Anders, A Dimitrios Colevas, Troy E Messick, Michelle A Rudek
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK-2019, a selective EBNA1 inhibitor. Biomedical chromatography : BMC (2023)
Amanda B Kagan, Nicole M Anders, Avelina Hemingway, Eudocia Q Lee, Kevin R Kelly, Hans C Lee, Meng Xu-Welliver, Richard L Piekarz, Michelle A Rudek
Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry. Biomedical chromatography : BMC 36 (11) (2022)
Susan C Scott, Nicole M Anders, Ping He, Avelina Hemingway, Steven D Gore, Christine L Hann, Michelle A Rudek
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax. Biomedical chromatography : BMC (2021)
Evanthia T Roussos Torres, Christine I Rafie, Chenguang Wang, David Lim, Adam Brufsky, Patricia LoRusso, Joseph Paul Eder, Vincent Chung, Melinda Downs, Molly Geare, Richard L Piekarz, Howard Streicher, Leslie Anforth, Michelle A Rudek, Qingfeng Zhu, Sepideh Besharati, Ashley Cimino-Mathews, Robert A Anders, Vered Stearns, Elizabeth D Thompson, Roisin M Connolly
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Roisin M Connolly, Eric Laille, Ulka Vaishampayan, Vincent Chung, Karen Kelly, Afshin Dowlati, Olatunji B Alese, Robert Donald Harvey, Paul Haluska, Lillian L Siu, Shivaani Kummar, Richard Piekarz, S Percy Ivy, Nicole M Anders, Melinda Downs, Ashley O'Connor, Angela Scardina, Jacqueline Saunders, Gary L Rosner, Michelle A Rudek, null null
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Razelle Kurzrock, Douglas W Ball, Marianna L Zahurak, Barry D Nelkin, Vivek Subbiah, Shabina Ahmed, Ashley O'Connor, Enusha Karunsena, Rose M Parkinson, Justin A Bishop, Yoonji Ha, Rajni Sharma, Christopher D Gocke, Ralph Zinner, Michelle A Rudek, Steven I Sherman, Nilofer S Azad
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (18) (2019)

Michelle A Rudek.css-eqlu8i{font-size:small;padding-left:4px;} (Michael A Carducci)

Publication Activity (10 Years)

Top Topics

Top Venues

Michelle A Rudek (Michael A Carducci)